Article info
PDFOriginal Article
A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy
- Correspondence to Seiji Mabuchi, Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan; smabuchi{at}gyne.med.osaka-u.ac.jp
Citation
A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy
Publication history
- Received August 25, 2018
- Revision received October 25, 2018
- Accepted November 2, 2018
- First published January 4, 2019.
Online issue publication
October 13, 2020
Article Versions
- Previous version (10 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.